Ignite Creation Date:
2024-05-06 @ 7:49 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06143839
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2023-11-16
Brief Title:
VYxeoS Liposomal Italian Observational Study iN the Real Practice
Sponsor:
Jazz Pharmaceuticals
Organization:
Jazz Pharmaceuticals
Study Overview
Official Title:
VYxeoS Liposomal Italian Observational Study iN the Real Practice
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VYSION
Brief Summary:
The study is a prospective single-arm non-experimental observational study in patients in Italy with Acute Myeloid Leukaemia AML with myelodysplastic-related changes or therapy related AML initiating treatment with JZP351 Vyxeos liposomal in their normal clinical practice
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None